416O - Efficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus: Results from the randomized, phase 2 LUNA study
Autor: | Ferolla, P., Brizzi, M.P., Meyer, T., Mansoor, W., Mazieres, J., Cao, C.D., Lena, H., Berruti, A., Damiano, V., Buikhuisen, W., Stankovic, M., Singh, N., Chiodini, E., Gislimberti, G., Oberg, K., Baudin, E. |
---|---|
Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi136-vi136 |
Databáze: | ScienceDirect |
Externí odkaz: |